Nebula Genomics

Founded in 2016 and headquartered in Boston, US, Nebula Genomics offers genomic sequencing services. The company was co-founded by Kamal Obbad, who has a history of entrepreneurial ventures.Nebula Genomics offers advanced genomic sequencing services, with a focus on 30x whole genome sequencing as its core product. This service enables individuals to obtain comprehensive insights into their genetic makeup, which can inform health decisions and ancestry tracing. The company’s sequencing technology is designed to provide high-quality, accurate results that cater to both personal interests and clinical applications. Primarily targeting consumers interested in personal genomics, Nebula Genomics serves a diverse client base that includes health-conscious individuals, researchers, and those curious about their genetic heritage.Nebula Genomics generates revenue through direct consumer sales of its genomic sequencing services, primarily operating on a subscription model. Clients can purchase the 30x whole genome sequencing service, which includes an initial fee for sequencing and ongoing access to reports and updates regarding their genomic data. The structure of transactions typically involves direct sales to consumers, allowing for a seamless purchasing experience. By providing detailed genomic insights through its flagship sequencing service, Nebula Genomics aims to establish itself as a leader in personalized genomics.In the coming years, Nebula Genomics plans to expand its product offerings by introducing new genomic analysis tools aimed at enhancing user experience. The company is also targeting international markets including Asia and Europe for expansion by 2024.3 mn will be utilized to support these initiatives, particularly in product development and market penetration strategies.

1. Series A

   Aug 29, 2018

   Amount

   $4.3M

   Investors

   Locked